AxoGen Inc

General ticker "AXGN" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $633.6M

AxoGen Inc follows the US Stock Market performance with the rate: 50.9%.

Estimated limits based on current volatility of 3.9%: low 15.41$, high 16.65$

Factors to consider:

  • Current price 35.8% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.52$, 11.97$]
  • 2024-12-30 to 2025-12-30 estimated range: [6.20$, 13.22$]

Financial Metrics affecting the AXGN estimates:

  • Negative: Non-GAAP EPS, $ of -0.18 <= 0.10
  • Negative: Operating profit margin, % of -11.89 <= 1.03
  • Negative: Operating cash flow per share per price, % of -1.85 <= 2.35
  • Positive: Inventory ratio change, % of 0.64 <= 1.08
  • Negative: Industry earnings per price (median), % of -6.44 <= 1.31

Similar symbols

Short-term AXGN quotes

Long-term AXGN plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $127.36MM $138.58MM $159.01MM
Operating Expenses $152.77MM $168.29MM $180.47MM
Operating Income $-25.42MM $-29.71MM $-21.46MM
Non-Operating Income $-1.57MM $0.76MM $-0.25MM
Interest Expense $1.36MM $0.62MM $2.83MM
R&D Expense $24.18MM $27.16MM $28.33MM
Income(Loss) $-26.98MM $-28.95MM $-21.72MM
Profit(Loss) $-26.98MM $-28.95MM $-21.72MM
Stockholders Equity $112.55MM $101.00MM $95.67MM
Inventory $16.69MM $18.91MM $23.02MM
Assets $208.02MM $195.39MM $196.83MM
Operating Cash Flow $-13.40MM $-16.07MM $-5.72MM
Capital expenditure $28.40MM $21.25MM $14.92MM
Investing Cash Flow $-23.65MM $-3.20MM $19.25MM
Financing Cash Flow $20.45MM $1.79MM $1.95MM
Earnings Per Share* $-0.68 $-0.65 $-0.51

* EPS are Split Adjusted, recent splits may be reflected with a delay.